Dendreon Corporation (DNDN) Stock Ratings


View Stock Quote:

DNDN

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bearish

50% of 2 ratings

View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
JOKER66 05/10/2013 1 day $4.03 $3.81 -5.46% 5 Ended
Comments:
maybedooo 04/19/2013 1 week $4.33 $4.36 +0.69% 1 Ended
Comments:
gary_41 02/25/2013 3 months $5.83 $4.01 -31.22% -31 Active
Comments: Dendreon's Provenge has been proven to help prostrate cancer patients, and will be approved for Eur
drulebucket 01/13/2013 3 months $6.17 $4.63 -24.96% 24 Ended
Comments:
SwissMaestro 06/04/2012 1 Year $6.76 $4.01 -40.68% 40 Active
Comments: This stock is overvalued
primadarwin 04/16/2012 3 months $8.85 $6.05 -31.64% -31 Ended
Comments: Just had a good earnings report
rc777 03/05/2012 3 months $10.65 $6.76 -36.53% -36 Ended
Comments: very beat down, but ramping up slowly
Panni 02/16/2012 3 months $14.57 $8.84 -39.33% -39 Ended
Comments: This stock is undervalued
Paul_136 02/12/2012 1 Year $14.05 $6.72 -52.17% -52 Ended
Comments: Just had a good earnings report
talehad 02/17/2011 1 month $33.96 $6.41 -81.12% -81 Ended
Comments: This stock is undervalued
edsimmons 12/10/2010 1 month $37.48 $6.41 -82.9% -82 Ended
Comments: Upcoming product launch will be successful
Rico11_2 02/02/2010 3 months N/A Ended
Comments:

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.